Top CRO M&A activity of 2016

By Melissa Fassbender

22-Dec-2016 - Last updated on 22-Dec-2016 at 14:48 GMT

As 2016 comes to a close, Outsourcing-Pharma.com looks back at some of the major mergers and acquisitions from the past year.

Merger mania

Quintiles

Charles River Laboratories

ICON

Parexel

Pharmaceutical Product Development (PPD)

Related tags: Mergers and acquisitions

Related news

Related products

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Survey Report: State of the global pharmaceutical contract services industry 2018

William Reed | 11-Jul-2018 | Research Study

In May 2018 Outsourcing-Pharma.com, in association with InnovoCommerce, conducted its second annual ‘state of the industry’ survey on its user base of...